RN7SL316P

Across TCGA pan-cancer cohorts, RN7SL316P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RN7SL316P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL316P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL316P expression acts as an unfavorable survival marker, although some lineages such as KIRP and THYM show a favorable association.

KIRC, KICH, and ACC are the cancer types where RN7SL316P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.503	0.700	<.001	131	view →
KICH	OS	Tertile	All	0.690	0.982	<.001	108	view →
ACC	OS	Tertile	All	0.615	0.945	<.001	45	view →
UCEC	DFS	Tertile	IV	0.257	0.632	.011	36	view →
THCA	DFS	Quartile	III,IV	0.494	0.818	.008	34	view →
KIRP	DFS	Quartile	III,IV	0.715	0.126	.003	31	view →
CESC	DFS	Tertile	II,III,IV	0.639	0.815	.022	24	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	18	view →
THYM	OS	Median	All	0.956	0.601	.010	15	view →
UVM	OS	Tertile	III,IV	0.220	0.872	.025	9	view →
PAAD	DFS	Tertile	III,IV	0.152	0.821	.045	9	view →
MESO	DFS	Tertile	All	0.260	0.395	.034	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RN7SL316P–KIRC (OS)

Open the KIRC breakdown →